A handful of biotech and pharmaceutical companies are kicking off earnings season this week, weaving Covid-19 updates into quarterly results tinged by the impact of a global pandemic. The virus continues to spread, with more than 3 million people worldwide now confirmed with the infection, as countries and U.S. states begin to ease lockdown restrictions.
This is CNBC’s live blog covering all…

Subscribe
Login
0 Comments
Oldest